Literature DB >> 28538186

An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity.

Wenli Zhang1, Jun Fu2, Jing Liu1, Hailong Wang2, Maren Schiwon1, Sebastian Janz1, Lukas Schaffarczyk1, Lukas von der Goltz1, Eric Ehrke-Schulz1, Johannes Dörner1, Manish Solanki1, Philip Boehme1, Thorsten Bergmann1, Andre Lieber3, Chris Lauber4, Andreas Dahl5, Andreas Petzold5, Youming Zhang6, A Francis Stewart7, Anja Ehrhardt8.   

Abstract

Adenoviruses (Ads) are large human-pathogenic double-stranded DNA (dsDNA) viruses presenting an enormous natural diversity associated with a broad variety of diseases. However, only a small fraction of adenoviruses has been explored in basic virology and biomedical research, highlighting the need to develop robust and adaptable methodologies and resources. We developed a method for high-throughput direct cloning and engineering of adenoviral genomes from different sources utilizing advanced linear-linear homologous recombination (LLHR) and linear-circular homologous recombination (LCHR). We describe 34 cloned adenoviral genomes originating from clinical samples, which were characterized by next-generation sequencing (NGS). We anticipate that this recombineering strategy and the engineered adenovirus library will provide an approach to study basic and clinical virology. High-throughput screening (HTS) of the reporter-tagged Ad library in a panel of cell lines including osteosarcoma disease-specific cell lines revealed alternative virus types with enhanced transduction and oncolysis efficiencies. This highlights the usefulness of this resource.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Red/ET homologous recombination; adenovirus; engineered adenovirus library; large double-stranded DNA viruses; natural virus diversity; resource; therapy; translation; vector

Mesh:

Year:  2017        PMID: 28538186     DOI: 10.1016/j.celrep.2017.05.008

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.995


  23 in total

Review 1.  Getting genetic access to natural adenovirus genomes to explore vector diversity.

Authors:  Wenli Zhang; Anja Ehrhardt
Journal:  Virus Genes       Date:  2017-07-15       Impact factor: 2.332

Review 2.  Barriers to systemic application of virus-based vectors in gene therapy: lessons from adenovirus type 5.

Authors:  Franziska Jönsson; Florian Kreppel
Journal:  Virus Genes       Date:  2017-07-28       Impact factor: 2.332

3.  A Zoonotic Adenoviral Human Pathogen Emerged through Genomic Recombination among Human and Nonhuman Simian Hosts.

Authors:  Shoaleh Dehghan; Jason Seto; Elizabeth B Liu; Ashrafali M Ismail; Ramana Madupu; Albert Heim; Morris S Jones; David W Dyer; James Chodosh; Donald Seto
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

Review 4.  Retargeting adenoviruses for therapeutic applications and vaccines.

Authors:  Michael A Barry; Jeffrey D Rubin; Shao-Chia Lu
Journal:  FEBS Lett       Date:  2020-02-03       Impact factor: 4.124

5.  One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors.

Authors:  Maren Schiwon; Eric Ehrke-Schulz; Andreas Oswald; Thorsten Bergmann; Thomas Michler; Ulrike Protzer; Anja Ehrhardt
Journal:  Mol Ther Nucleic Acids       Date:  2018-06-07       Impact factor: 8.886

Review 6.  Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines.

Authors:  Lynda Coughlan
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

7.  Human adenovirus type 17 from species D transduces endothelial cells and human CD46 is involved in cell entry.

Authors:  Jing Liu; Philip Boehme; Wenli Zhang; Jun Fu; Roma Yumul; Kemal Mese; Raphael Tsoukas; Manish Solanki; Michael Kaufmann; Ruirui Lu; Achim Schmidtko; A Francis Stewart; André Lieber; Anja Ehrhardt
Journal:  Sci Rep       Date:  2018-09-07       Impact factor: 4.379

8.  CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes.

Authors:  Eric Ehrke-Schulz; Maren Schiwon; Theo Leitner; Stephan Dávid; Thorsten Bergmann; Jing Liu; Anja Ehrhardt
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379

Review 9.  Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy.

Authors:  Jian Gao; Wenli Zhang; Anja Ehrhardt
Journal:  Cancers (Basel)       Date:  2020-05-02       Impact factor: 6.639

10.  Effect of cold atmospheric plasma (CAP) on human adenoviruses is adenovirus type-dependent.

Authors:  Oskar Bunz; Kemal Mese; Wenli Zhang; Andree Piwowarczyk; Anja Ehrhardt
Journal:  PLoS One       Date:  2018-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.